Dashboard
Manage Tickers

IPA MindWalk Holdings Corp.


$ 1.62 $ -0.07 (-4.09 %)    

Thursday, 16-Oct-2025 18:21:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.04 $ -2.23 (-0.37 %)
DIA $ 458.55 $ -3.15 (-0.68 %)
SPY $ 658.55 $ -4.53 (-0.68 %)
TLT $ 91.43 $ 0.68 (0.75 %)
GLD $ 402.27 $ 9.06 (2.34 %)
$ 1.64
$ 1.77
$ 1.63 x 100
$ 1.85 x 1,000
$ 1.61 - $ 1.78
$ 0.27 - $ 3.25
602,615
na
na
$ 1.24
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

immunoprecise-rebrands-as-mindwalk-unifies-subsidiaries-and-changes-ticker-to-hyft
ImmunoPrecise Rebrands As MindWalk, Unifie...
09/03/2025 12:52:13

An Evolution in Name, Structure, and Strategy Reflecting the Company's AI-Driven Platform and Bio-Native Discovery Vision

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

immunoprecise-antibodies-says-advancing-to-pre-clinical-manufacturing-for-in-vivo-testing-and-virus-neutralization-analysis
ImmunoPrecise Antibodies Says Advancing To...
08/27/2025 12:23:49

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/25/2025 17:07:46

avs-bio-acquires-immunoprecise-antibodies-europe-to-expand-its-european-footprint-and-add-capabilities-in-antibody-discovery-protein-expression-and-organoi-growth-factor-development-and-manufacturing-to-portfolio
AVS Bio Acquires ImmunoPrecise Antibodies ...
08/06/2025 12:17:43

immunoprecise-antibodies-divests-its-netherlands-facilities-to-avs-bio-for-total-enterprise-value-of-12m
ImmunoPrecise Antibodies Divests Its Nethe...
08/06/2025 12:13:04

immunoprecise-antibodies-q4-2025-eps-004-misses-002-estimate-sales-5050m-miss-5980m-estimate
ImmunoPrecise Antibodies Q4 2025 EPS $(0.0...
07/29/2025 12:39:56

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

immunoprecise-antibodies-announces-results-of-a-newly-expanded-study-demonstrating-that-its-lensai-immunogenicity-screening-can-reliably-predict-anti-drug-antibody-risk-for-therapeutic-proteins-before-they-enter-animal-studies-or-human-trials
Immunoprecise Antibodies Announces Results...
07/24/2025 12:29:25

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("IPA" or the "Company"), a Bio-Native AI pioneer operating where Te...

immunoprecises-lensai-achieves-ability-to-accurately-predict-binding-on-17-previously-unseen-antibody-antigen-complexes-achieving-near-crystallography-precision-without-prior-training-data
ImmunoPrecise's LENSai Achieves Ability To...
07/03/2025 12:21:22

New benchmark confirms LENSai's ability to accurately predict binding on 17 previously unseen antibody-antigen complexes, a...

immunoprecise-confirms-ai-discovered-dengue-vaccine-target-is-safe-and-triggers-immune-response
ImmunoPrecise Confirms AI-Discovered Dengu...
06/24/2025 11:11:02

ImmunoPrecise (NASDAQ:IPA), a leader in AI-driven biotherapeutics, provides a significant update following its June 5, 2025, pr...

immunoprecise-antibodies-announces-in-vitro-results-demonstrating-its-glp-1ra-peptide-sequences-achieve-comparable-or-superior-receptor-activation-to-semaglutide
ImmunoPrecise Antibodies Announces In Vitr...
06/12/2025 12:03:07

immunoprecises-ai-powered-lensai-platform-driven-by-patented-hyft-technology-identifies-a-highly-conserved-multi-factorial-epitope-across-all-four-dengue-virus-serotypes
ImmunoPrecise's AI-Powered LENSai Platform...
06/05/2025 12:09:16

LENSai™ powered by HYFT® technology Identifies a single multi-factorial target conserved across all dengue serotypes.ImmunoPrec...

immunoprecise-announces-benchmarking-results-for-lensai-epitope-mapping
ImmunoPrecise Announces Benchmarking Resul...
05/12/2025 12:11:05

ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, is pleased to announce today new benchm...

hc-wainwright--co-reiterates-buy-on-immunoprecise-antibodies-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Immu...
04/11/2025 15:55:35

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maint...

immunoprecise-antibodies-announces-its-support-for-fdas-recent-decision-to-phase-out-animal-testing-requirements-for-monoclonal-antibodies-and-other-pharmaceutical-products
ImmunoPrecise Antibodies Announces Its Sup...
04/11/2025 12:42:44

ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, today announced its strong support for ...

benchmark-reiterates-speculative-buy-on-immunoprecise-antibodies-maintains-3-price-target
Benchmark Reiterates Speculative Buy on Im...
04/01/2025 14:44:49

Benchmark analyst Robert Wasserman reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Speculative Buy and maintains $3 ...

hc-wainwright--co-maintains-buy-on-immunoprecise-antibodies-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on Immun...
03/31/2025 10:42:36

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and lowers...

immunoprecise-antibodies-q3-2025-gaap-eps-c066-may-not-be-comparable-to-c008-estimate-sales-c615m-miss-c658m-estimate
ImmunoPrecise Antibodies Q3 2025 GAAP EPS ...
03/28/2025 12:05:36

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimat...

earnings-scheduled-for-march-28-2025
Earnings Scheduled For March 28, 2025
03/28/2025 08:32:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION